Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Bio-Rad to Report Second-Quarter 2015 Financial Results Thursday, August 6, 2015

Marketwired July 10, 2015

Bio-Rad Announces FDA Clearance for Diagnosing Diabetes With Its VARIANT II TURBO HbA1c Kit - 2.0

Marketwired June 9, 2015

Bio-Rad Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and Hepatitis C Assays

Marketwired April 20, 2015

Bio-Rad to Report First-Quarter 2015 Financial Results Tuesday, May 5, 2015

Marketwired April 15, 2015

Bio-Rad Extends Availability of Its Vitamin D Kit for the BioPlex 2200 System in the U.S.

Marketwired April 13, 2015

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Bio-Rad Laboratories, Inc.

PR Newswire November 12, 2014

Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad Laboratories, Inc., Pingtan Marine Enterprise Ltd., Rayonier Inc. and Salix Pharmaceuticals, Ltd.

PR Newswire November 11, 2014

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces an Investigation into Possible Breaches of Fiduciary Duties by the Board of Directors of Bio-Rad Laboratories, Inc.

Business Wire November 7, 2014

Ryan & Maniskas, LLP Announces Investigation of Bio-Rad Laboratories, Inc.

PR Newswire November 5, 2014

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Bio-Rad Laboratories, Inc.

Business Wire November 4, 2014

Faruqi & Faruqi, LLP is Investigating Bio-Rad Laboratories, Inc. (BIO) on Behalf of its Shareholders

PR Newswire November 4, 2014

Robbins Arroyo LLP Is Investigating the Officers and Directors of Bio-Rad Laboratories, Inc. (BIO) on Behalf of Shareholders

PR Newswire November 4, 2014

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces an Investigation into Possible Breaches of Fiduciary Duties by the Board of Directors of Bio-Rad Laboratories, Inc.

PR Newswire November 4, 2014

Bio-Rad Named One of the '2014 Best Places to Work in the Bay Area'

Marketwired April 28, 2014

BioAlliance Pharma announces participation in the Smallcap Event On April 7th and 8th 2014 in Paris

Thomson Reuters ONE March 28, 2014

BioAlliance Pharma : FDA Grants Validive® (clonidine Lauriad®) with a Fast Track Designation for the Prevention and Treatment of Oral Mucositis Induced by Anticancer Treatments

Business Wire January 23, 2014

BioAlliance Pharma Strengthens Sitavig Patent Protection with New U.S. and South Korean issued Patents

Business Wire November 14, 2013

BioAlliance Pharma Announces Third Positive DSMB Recommendation to Continue Its Phase III Clinical Trial with Livatag® in Primary Liver Cancer

Business Wire October 22, 2013

Bio-Rad's Tour de Cure National Team Raises Over $125,000

Marketwired August 27, 2013

Bio-Rad Reports Second-Quarter 2013 Financial Results

Marketwired August 6, 2013